Nagoya Firm Discovers A System To Deliver Drugs Into Brain
This article was originally published in PharmAsia News
Executive Summary
Nagoya-based Tissue Targeting Japan Inc. has developed the T2J peptide, a synthetic molecule that is able to permeate the blood-brain barrier and deliver drugs and materials directly inside human brains. Until now, the blood-brain barrier has blocked viruses and toxins as well as drugs from entering the brain. The T2J research team discovered that the microglial cell, a certain kind of glial cell, which accounts for 90 percent of brain cells, has the ability to permeate the brain blood barrier. Modeled after the microglial cell's movement pattern inside the brain, the T2J peptide can deliver chemicals directly to the brain. Tissue Targeting Japan will strengthen joint research with pharmaceutical companies and expects to launch a new drug using the peptide in 2015. (Click here for more-Japanese language